Published online Aug 15, 2017. doi: 10.4239/wjd.v8.i8.390
Peer-review started: November 3, 2016
First decision: February 15, 2017
Revised: March 12, 2017
Accepted: April 18, 2017
Article in press: April 19, 2017
Published online: August 15, 2017
Core tip: This study compares obesity and diabetes rates between schizophrenia patients treated in a community mental health center and a local population control. It demonstrates that prevalence of obesity and diabetes is significantly higher in patients with schizophrenia, which is consistent with previous research. In this cross-sectional study, second generation antipsychotic use and antipsychotic dosage were not correlated with obesity categories or diabetes status. This implies that antipsychotics alone may not be responsible for the increased diabetes risk in schizophrenia patients. Many factors may contribute to risk, including an inherent vulnerability to diabetes in schizophrenia patients that has been seen in earlier studies.